Generic drug
Daunorubicin price, strengths & recalls
Daunorubicin has no weekly pharmacy acquisition cost. 2 manufacturers make it. It has 2 recalls on record, none ongoing. Its official label last changed on February 9, 2023.
GenericDaunorubicin price by strength
What pharmacies pay for each strength and form this week, for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 5 mg/mL, 4 mL injection | Not priced this week | |||
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Daunorubicin
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
DAUNORUBICIN HYDROCHLORIDE INJECTION Rx ONLY
WARNING
Daunorubicin Hydrochloride Injection must be given into a rapidly flowing intravenous infusion. It must never be given by the intramuscular or subcutaneous route. Severe local tissue necrosis will occur if there is extravasation during administration.
Myocardial toxicity manifested in its most severe form by potentially fatal congestive heart failure may occur either during therapy or months to years after termination of therapy. The incidence of myocardial toxicity increases after a total cumulative dose exceeding 400 to 550 mg/m
2 in adults, 300 mg/m
2 in children more than 2 years of age, or 10 mg/kg in children less than 2 years of age.
Severe myelosuppression occurs when used in therapeutic doses; this may lead to infection or hemorrhage.
It is recommended that daunorubicin hydrochloride be administered only by physicians who are experienced in leukemia chemotherapy and in facilities with laboratory and supportive resources adequate to monitor drug tolerance and protect and maintain a patient compromised by drug toxicity. The physician and institution must be capable of responding rapidly and completely to severe hemorrhagic conditions and/or overwhelming infection.
Dosage should be reduced in patients with impaired hepatic or renal function.
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Generic makers
- 2 approved generic applications on the market
Daunorubicin questions
Is daunorubicin in shortage?
No shortage is reported for daunorubicin right now. We check the national shortage list every day.
Has daunorubicin been recalled?
2 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the daunorubicin label last change?
The official label was last updated on February 9, 2023 (version 4). See what changed.
Talk about daunorubicin
No comments yet. Questions, tips, what worked for you - start the conversation.